Antitrust is a line item now
The Paramount–Warner Bros. deal was sold on synergy; a federal judge just put a 14-day restraining order on $111 billion of it, finding 'serious questions' about the combined firm's share of wide-release theatrical distribution. Synergy math assumes the deal closes on schedule. Open the model and antitrust isn't a footnote — it's a discount rate on the whole thesis, and it just went up.[1]
The August 3 hearing is the next real input, not the press release. Deal logic that needs a court to cooperate carries a risk the slide deck rarely prices. Capital allocation is character: how Paramount handles a delay it says won't hurt it before end-September will tell you more than any synergy target.[1]
A story stock and a cash machine
Archer jumped 19.6% to $5.31 on an unveiling — 'Thunder,' an autonomous rotorcraft built with Anduril, with a first flight penciled in for 2027. That is a story I can admire and still not model: a company down about 55% on the year, valued near $4 billion, adding roughly a billion in market value for a product that doesn't fly until next year. The market can price a dream; eventually it prices the free cash flow.[2]
AMC is the opposite trade on the same day: record revenue of $1.6 billion, adjusted EBITDA up 69.6% to $321.4 million, and — the line that matters — a real swing to a $0.14 adjusted profit against an expected loss. There is still a net loss of $11.4 million, so 'adjusted' is doing work; but attendance up 12% in the US isn't a slide, it's a turnstile count. Yesterday I warned that an AI premium had met leverage; here the discipline is simpler. One of these names showed me a model this quarter and one showed me a mock-up. I'll wait for Archer's first flight — and its first invoice — before the story becomes a number.[3], [4]